No results for ‘’
Strides Pharma Science Ltd
₹1223.10
(0.97%)
Fri, 25 Sept 2026, 06:27 pm
Health Technology
Pharmaceuticals: Major
24.5KStrides Pharma Science Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 27.91 | 27.86 | 27.86 | 28.30 | 28.30 |
| FII | 28.68 | 29.52 | 28.51 | 28.02 | 28.32 |
| DII | 14.45 | 13.02 | 12.98 | 13.30 | 13.72 |
| Public | 28.95 | 29.59 | 30.64 | 30.37 | 29.65 |
| Government | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Strides Pharma Science Ltd Shareholding Pattern
The Strides Pharma Science Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Strides Pharma Science Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Strides Pharma Science Ltd (NSE: STAR, BSE: 532531) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Strides Pharma Science Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Strides Pharma Science Ltd Shareholding Pattern (Latest)
The latest Strides Pharma Science Ltd shareholding for Mar 2026 is:
- Promoters: 27.91%
- FII: 28.68%
- DII: 14.45%
- Public: 28.95%
- Government: 0.01%
Promoter holding in Strides Pharma Science Ltd has increased, indicating strong confidence from company promoters.
Strides Pharma Science Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Strides Pharma Science Ltd.
- Mar 2026: 27.91%
- Dec 2025: 27.86%
- Sept 2025: 27.86%
- Jun 2025: 28.30%
- Mar 2025: 28.30%
Promoter stake in Strides Pharma Science Ltd has increased, indicating strong long-term confidence.
Strides Pharma Science Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Strides Pharma Science Ltd.
- Mar 2026: 28.68%
- Dec 2025: 29.52%
- Sept 2025: 28.51%
- Jun 2025: 28.02%
- Mar 2025: 28.32%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Strides Pharma Science Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 14.45%
- Dec 2025: 13.02%
- Sept 2025: 12.98%
- Jun 2025: 13.30%
- Mar 2025: 13.72%
DII stake in Strides Pharma Science Ltd has increased over time, indicating growing domestic institutional confidence.
Strides Pharma Science Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 28.95%
- Dec 2025: 29.59%
- Sept 2025: 30.64%
- Jun 2025: 30.37%
- Mar 2025: 29.65%
Public holding remains stable with consistent retail participation.
Strides Pharma Science Ltd Government Holding
Government holding in Strides Pharma Science Ltd currently stands at 0.01%.
Government presence indicates institutional backing and regulatory confidence.
Strides Pharma Science Ltd Shareholding Analysis Summary
The Strides Pharma Science Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Strides Pharma Science Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Strides Pharma Science Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.